Eurofins SAFER@WORK™ US
BiotechnologyMassachusetts, United States0-1 Employees
Eurofins SAFER@WORK™ US operates within the biotechnology research sector, focusing on workplace safety solutions related to COVID-19 risk management. The program combines environmental and clinical testing with consultative services to help organizations reduce virus presence and allocate limited clinical testing resources more effectively, potentially lowering overall costs while supporting public health efforts. Its approach emphasizes testing of workplace surfaces and wastewater alongside risk-based clinical testing to prioritize human testing where it is likelier to detect the virus. Based in Framingham, Massachusetts, the entity is part of a broader Eurofins effort and engages expert partners and Eurofins government-licensed clinical laboratories to implement its programs. A recent development noted in the provided information highlights collaborations involving Eurofins QTA Inc., illustrating continued activity in partnerships across testing and environmental services.
1-888-653-2347 
support@leadiq.com 
